ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

129
Analysis
Health Care • United States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
Company Presentation • 12 Jun 2026 22:30

AGM 2026

Company Presentation • 09 Jan 2024 06:15

J.P. Morgan 42nd Annual Healthcare Conference 2024

Company Presentation • 30 Jan 2026 21:30

Q4 2025

Company Presentation • 13 Jan 2026 01:12

44th Annual J.P. Morgan Healthcare Conference

Company Presentation • 14 Jan 2025 06:15

43rd Annual J.P. Morgan Healthcare Conference 2025

x